Back to announcement
20250311_EMTK_Laporan Informasi dan Fakta Material_31868300_lamp1.pdf
Other Text extracted EMTKSource file signed link, expires in 15 minutes
Extracted text 5
Page 1
Unofficial Translation
INFORMATION DISCLOSURE TO THE SHAREHOLDERS
IN CONNECTION WITH THE CAPITAL INCREASE WITHOUT PRE-
EMPTIVE RIGHTS ("PMTHMETD") THROUGH MANAGEMENT AND
EMPLOYEE STOCK OWNERSHIP PROGRAM ("MESOP PROGRAM")
PT Elang Mahkota Teknologi Tbk
(The “Company”)
Field of Business:
Engage in Service (professional activities, media, solution, information technology, connectivity,
healthcare, aviation support services as well as banking services) and Trade through Subsidiaries.
Head Office:
SCTV Tower, Senayan City 18th Floor,
Jl. Asia Afrika Lot 19
Jakarta Pusat 10220 - Indonesia
Phone: +62 21 7278 2066
Fax: +62 21 7278 2194
E-mail: corsec@emtek.co.id
Website: www.emtek.co.id
This Information Disclosure to the Shareholders is addressed to the Company’s Shareholders in
relation to Company’s plan of conducting Management and Employee Stock Ownership Program (the
“MESOP Program”) by granting shares for free without option rights to the program’s participants,
through issuance of new shares without pre-emptive rights for a maximum of 300,000,000 shares or
representing 0.49% of the total issued and fully paid-up capital of the Company in accordance with
applicable laws and regulations.
According to this MESOP Program, the shareholders of the Company will be subject to a dilution of
their ownership for a maximum of 0.49% up to the end of the MESOP Program. The dilution
estimation is an estimate without considering the Company's corporate action in the form of Capital
Increases without Pre-emptive Rights (PMTHMETD).
The General Meeting of Shareholders to approve this plan will be convened in Jakarta on 28 April
2025.
The Board of Commissioners and the Board of Directors, either individually or collectively, are fully
held responsible for the completeness and accuracy of all the information and material facts contained
herein and hereby confirm that the information disclosed in this Information Disclosure is accurate
and there is no of unstated material facts that can cause material information in this Information
Disclosure become inaccurate and/or misleading.
This Information Disclosure is issued on 12 March 2025
1
Page 2
Unofficial Translation
I. REASONS AND PURPOSE OF MESOP PROGRAM
The Company is engaged in the service (professional activities, media, solution, information technology,
connectivity, healthcare, aviation support services as well as banking services) and trade through
Subsidiaries.
The Company believes that consistent performance improvement from year to year can be achieved due
to commitment from management and employees. The Company will continue to implement
appropriate strategies to deliver maximum performance for the Company and maintain sustainable
growth. One of the strategies is through the MESOP Program that aims to increase the sense of
ownership of the Company. Further, this program intends to improve the performance of each
participant of the MESOP Program, which will indirectly increase the Company’s performance in the
long run.
The Company will execute Capital Increases without Pre-emptive Rights ("PMTHMETD") through the
MESOP Program by issuing free shares to program’s participants, in which new shares will be issued
from portfolios with a maximum of 300,000,000 shares or representing 0.49% of the total issued and
fully paid-up capital of the Company. The Company will make the distribution and payment in
accordance with applicable laws and regulations.
MESOP Program shall be conducted by the Company in accordance with the Financial Services
Authority Regulation Number 14/POJK.04/2019 concerning Amendment of the Financial Services
Authority Regulation Number 32/POJK.04/2015 concerning Capital Increases in Public Companies
With Pre-Emptive Rights (“POJK No. 14/2019”).
II. INFORMATION CONCERNING MESOP PROGRAM
The MESOP Program is a program offered to employees, members of the Board of Directors and/or
members of the Board of Commissioners of the Company and/or Controlled Company that are eligible
to own the shares of the Company. This program is conducted by granting free shares to eligible program
participants based on new shares to be issued by the Company with a maximum of 300,000,000 (three
hundred million) shares at the exercise price to be determined by the Board of Directors with the
approval of the Board of Commissioners of the Company. The exercise of this program is made pursuant
to provisions of Article V Enclosure II of Listing Regulation of PT Bursa Efek Indonesia No. I-A Decision
No. Kep-00101/BEI/12-2021 dated 21 December 2021 concerning Amendment to Regulations
concerning Listing of Shares and Equity Securities Other Than Shares Issued by the Listed Company
("Rule No. I-A").
1. MESOP Program Participants
The categories of the MESOP Program participants who are entitled will be determined by the
Company's Board of Directors with the approval of the Company's Nomination and Remuneration
Committee, as follows:
a. members of the Board of Commissioners of the Company and Controlled Company, who served
at the time of distribution of free shares as part of their compensation;
b. members of the Board of Directors of the Company and Controlled Company who served at the
time of distribution of free shares as part of their compensation; and
c. Employees of the Company and Controlled Company with Grade 15 or above that are registered
in the Company and Controlled Company's employee data who have worked for at least 6 (six)
months prior to the date of distribution of free shares as part of their compensation in each
distribution stage.
2. Shares Distribution Period
The MESOP Program will be implemented within maximum 5 (five) years from the approval date of
the Company’s General Meeting Shareholders, which approved this MESOP Program, until 2030.
2
Page 3
Unofficial Translation
If deemed relevant by the Board of Directors of the Company and the Company’s Remuneration
Committee, any shares of the Company distributed to MESOP Program’s participants will have a 4-
year vesting period in which the shares will be issued 25% annually. Dividends will not be granted
to the Company's shares that have not been issued and officially distributed to each participant of
the MESOP Program.
Shares will be distributed to MESOP Program participants in several stages to be determined by the
Board of Directors of the Company with prior approval from the Company’s Remuneration
Committee. The Company’s Remuneration Committee shall conduct share calculations to be
allocated to eligible participants based on the performance of the participants and with regards to
their duties and responsibilities in making decisions that have a significant impact on the Company's
performance.
3. Stipulation of the Shares Exercise Price
The stipulation of exercise price of the MESOP shares will be determined by the Board of Directors
with the approval of the Board of Commissioners of the Company with reference to the provisions
of Article V Enclosure II of Rule No. I-A, which stipulates the exercise price at least 90% of an average
closing price of the Company's shares for 25 (twenty five) consecutive days of stock trading prior to
the report to Indonesia Stock Exchange (“IDX”) concerning MESOP implementation or carried out
in accordance with prevailing laws and regulations on limited liability companies and capital market
as well as applicable accounting standards.
4. Status of MESOP Program Shares
Shares to be issued in connection with the MESOP Program shall have equal rights, position and
degree in all respects with fully paid-up shares in the Company. This includes the dividend rights
and may issue voting rights at the General Meeting of Shareholders as well as other corporate actions
to be carried out by the Company. All issued shares are new shares issued from the portfolio of the
Company and will be listed on the IDX in accordance with applicable laws and regulations.
5. MESOP Implementation
The MESOP program is conducted through the issuance of new shares issued without pre-emptive
rights. The implementation of MESOP can also use treasury shares owned by the Company which
will be determined by considering recommendations from the Company's Remuneration
Committee, while taking into account the prevailing laws and regulations and the best interests of
each shareholder of the Company.
6. The period of issuance and exercise of MESOP shall be determined subsequently regarding the
applicable capital market regulations.
7. MESOP Program Requirements
a. the Company has obtained the approval of the General Meeting of Shareholders;
b. the application for Pre-Listing of additional shares for the MESOP Program has been approved
by the IDX;
c. in the event of MESOP Program participants resigning from their positions from the Company
or Controlled Company, all shares that will be given but not yet fulfill the vesting period will be
forfeited and MESOP Program participants are not entitled to such shares. If the MESOP
Program participant is dismissed by the Company or Controlled Company, then all shares that
will be given but not yet fulfilled the vesting period will be forfeited and MESOP Program
participants will not be entitled to such shares; and
d. other requirements determined by the Board of Directors with the approval of the Company’s
Nomination and Remuneration Committee have been fulfilled.
3
Page 4
Unofficial Translation
Proforma of Capital and Shareholders Composition of the Company Before and After
the Issuance of New Shares in accordance with the Company’s Shareholders Registrar
as per 28 February 2025
Before the Issuance of After the Issuance of
the MESOP Program Shares the MESOP Program Shares
REMARKS Nominal
Number of Number of Nominal IDR20, -
IDR20, -/share
Shares % Shares /share (IDR) %
(IDR)
Authorized Capital 125,670,180,000 2,513,403,600,000 - 125,670,180,000 2,513,403,600,000 -
Issued and Paid-Up Capital:
1 Eddy K. Sariaatmadja 13,439,147,454 268,782,949,080 21.89% 13,439,147,454 268,782,949,080 21.78%
2 PT Adikarsa Sarana 8,654,560,360 173,091,207,200 14.10% 8,654,560,360 173,091,207,200 14.03%
3 Ir. Susanto Suwarto 7,117,889,090 142,357,781,800 11.59% 7,117,889,090 142,357,781,800 11.54%
4 Piet Yaury 4,989,564,500 99,791,290,000 8.13% 4,989,564,500 99,791,290,000 8.09%
5 PT Prima Visualindo 3,802,209,980 76,044,199,600 6.19% 3,802,209,980 76,044,199,600 6.16%
6 Anthoni Salim 5,510,302,220 110,206,044,400 8.98% 5,510,302,220 110,206,044,400 8.93%
7 Treasury Stock 243,946,550 4,878,931,000 0.40% 243,946,550 4,878,931,000 0.40%
8 Public 17,634,131,329 352,682,626,580 28.72% 17,634,131,329 352,682,626,580 28.58%
9 MESOP Program - - - 300,000,000 6,000,000,000 0.49%
Total Issued and Paid-
61,391,751,483 1,227,835,029,660 100% 61,691,751,483 1,233,835,029,660 100%
Up Capital
Shares in Portfolio 64,278,428,517 1,285,568,570,340 - 63,978,428,517 1,279,568,570,340 -
Therefore, after the implementation of the MESOP Program if all issued shares are new shares issued
from the portfolio shares of the Company, the shareholders will be subject to a dilution of their
ownership for a maximum of 0.49%.
III. ANNUAL GENERAL MEETING OF SHAREHOLDERS (“AGMS”)
In accordance with the provisions of the applicable laws and regulations, the MESOP Program will seek
approval at the Company's AGMS which will be held on:
Day & Date : Monday, 28 April 2025
Time : 14.00 Western Indonesian Time – until end
Venue : SCTV Studio 8th Floor, SCTV Tower - Senayan City
Jl. Asia Afrika Lot. 19, Central Jakarta, 10270, Indonesia
The Company has announced that the AGMS will be held through (i) the website of the e-GMS Provider
PT Kustodian Sentral Efek Indonesia (KSEI), (ii) the IDX’s website, and (iii) the Company's website
4
Page 5
Unofficial Translation
(www.emtek.co.id) on 12 March 2025 while the invitation to the AGMS is planned to be announced on
27 March 2025.
Specifically, the quorum provisions for approval of the MESOP Program as required in Article 8A
paragraphs (2) and (3) POJK No. 14/2019 are:
1. The GMS can be held if the GMS is attended by more than 1/2 (half) portion of the total amount of
shares with valid voting rights owned by independent shareholders and shareholders that are not
part of the parties affiliated with Public Companies, members of the Board of Directors, members
of the Board of Commissioners, major shareholders, or Controllers.
2. The GMS’ decision as referred to in number 1 are valid if approved by more than 1/2 (half) portion
of the total amount of shares with valid voting rights owned by independent shareholders and
shareholders that are not part of the parties affiliated with Public Companies, members of the Board
of Directors, members of the Board of Commissioners, major shareholders, or Controllers.
3. In the case of the quorum of GMS was not reached, then a second GMS can be held if the GMS is
attended by more than 1/2 (half) portion of the total amount of shares with valid voting rights
owned by independent shareholders and shareholders that are not part of the parties affiliated with
Public Companies, members of the Board of Directors, members of the Board of Commissioners,
major shareholders, or Controllers.
4. The second GMS’ decision is valid if approved by more than 1/2 (half) portion of the total amount
of shares with valid voting rights owned by independent shareholders and shareholders that are not
part of the parties affiliated with Public Companies, members of the Board of Directors, members
of the Board of Commissioners, major shareholders, or Controllers who are present at the GMS.
5. In the case of the attendance quorum at the second GMS was not reached, then a third GMS can be
held on condition that the third GMS is valid and can make a decision if attended by independent
shareholders and shareholders that are not part of the parties affiliated with Public Companies,
members of the Board of Directors, members of the Board of Commissioners, major shareholders,
or Controllers of shares with valid voting rights, in the attendance quorum determined by the
Financial Services Authority based upon an application filed by Public Companies.
6. The third GMS’ decision are valid if approved by independent shareholders and shareholders that
are not part of the parties affiliated with Public Companies, members of the Board of Directors,
members of the Board of Commissioners, major shareholders, or Controllers who represents more
than 50% (fifty percent) shares owned by independent shareholders and shareholders that are not
part of the parties affiliated with Public Companies, members of the Board of Directors, members
of the Board of Commissioners, major shareholders, or Controllers who are present at the GMS.
7. The implementation of the GMS must be carried out in accordance with the provisions as stipulated
in POJK No. 15/POJK.04/2020 concerning the Plan and Implementation of the General Meeting
of Shareholders of a Public Company and the articles of association of the Company, unless
otherwise specified in the regulation issued by the Financial Services Authority.
Jakarta, 12 March 2025
PT Elang Mahkota Teknologi Tbk
The Board of Directors
5
Names mentioned 12 people and organisations named in the text · linked when the evidence is strong
unresolved
org
Financial Services Authority
p.2 ×4
unresolved
org
PT Bursa Efek Indonesia No. I-A Decision
p.2
unresolved
org
Indonesia Stock Exchange
p.3
unresolved
org
PT Kustodian Sentral Efek Indonesia
p.4
Extraction attempts how the parser did, and what it refused
Nothing structured was extracted from this document — the attempts below say why.
No extraction attempted yet.